CNBC Stock Blog
- 10 Dividend Picks For Your Portfolio: Chief Investors
- 4 Thanksgiving Week Buys For Your Portfolio: Market Pros
- There's a 'Great Chance' For a Double-Dip Recession: Strategist
- Retail Earnings and Sales to Improve in Q4: Analyst
- 4 Food Stocks to Stuff in Your Portfolio: Analyst
- S&P at 1050-1200 Trading Range Next Year: Strategist
- Art Cashin: Caution 'Growing' in Financials, Dividend Moves
- 3 Software Stock Picks from Lazard's Senior Analyst
- Investors Bet on a New Year's Rally For eBay
- Why You Should Play the Reflation Trade: Stock Picker
MOST SHARED
- Garlic Price Rises Surpass Gold, Stocks in China
- New-Home Sales Jump 6.2% To Highest Level in Over Year
- S&P Stocks Trading at New 52-Week Highs
- Where Do Pardoned Turkeys Go?
- The Executive Job Search
- Judge Erases Couple's $525,000 Mortgage Payment
- Salvation Army's Kettles Now Credit Card-Ready
- US Plans to Reduce Emissions By 17% Within Next Ten Years
- US Mint to Suspend American Eagle Gold 1-Ounce Coins
- Consumer Mood Improves, But Anxiety Over Personal Finances
- 4 Thanksgiving Week Buys For Your Portfolio: Market Pros
- There's a 'Great Chance' For a Double-Dip Recession: Strategist
- Revenge of the Gangsta Nerds
- Will TCU See The "Flutie Effect?"
- Retail Earnings and Sales to Improve in Q4: Analyst
- Consumers Catching the Holiday Spirit
- It's Beginning To Look A Lot More Riskless
- Crescenzi: Claims Level Suggests End to Job Losses
- Hedge Funds Take Early Lead in Warren Buffett's 'Big Bet'
- AIG, Ex-CEO Greenberg Reach Pact to Settle Disputes
- Bank of America CEO Search May Extend Into 2010
- 'Cancer of Fraud' Permeates Health Care System: Critics
- US Mint to Suspend American Eagle Gold 1-Ounce Coins
- Judge Erases Couple's $525,000 Mortgage Payment
- For Many in US, It Will Be a Scaled-Down Holiday Season
- Where Do Pardoned Turkeys Go?
- Jobless Claims Below 500,000, Durable Orders Slip
- Activision Prepares to Double Dip on ‘Modern Warfare 2’
RSS FEED
Text Size 
CNBC News Associate
Investors ought to get ready for a bull market, said Brian Belski, chief investment strategist at Oppenheimer & Co. and Art Nunes, market strategist at IMS Capital Management. They shared their take on the markets with investors.
“We view this as a significant turning point and maybe the early stages of a longer-term bull market,” Nunes told CNBC and said he expects the S&P 500 to reach 1,200 by year-end.
“A lot of people are underinvested in this market and we’ve been climbing a wall of worry all year long,” he said and recommended investing in the Rydex S&P ETF [RSP
Loading...
()
].
In the meantime, Belski said he expects the S&P to reach 1,120 over the next 12 months.
“Stocks [will] continue to lead the economy and the stock market is telling us that the economic bottom is in place—now the engine of growth has to come back in and 2010 is going to be the year of the “show me” period,” he said. “In between there though, we believe stocks go higher, the economy recovers and equities will be the place to be.”
Belski added that investors should consider looking into the health care sector where he expects potential growth.
“We’ve betting on the fact that we’re not going to see a broad, nationalization of health care—we believe stocks are clearly priced for nationalization,” he said. “If you take a look at the strong intrinsic growth factors of health care, namely biotech, life sciences, devices and to some degree, HMOs and drugs, growth is clearly there. During the 3rd quarter, health care was the only sector of the 10 primary sectors in the market that was showing topline growth and that’s going to be a main theme going forth.”
______________________________
CNBC Slideshows:
______________________________
Top Biotech Companies:
Bristol-Myers [BMY
Loading...
()
]
Amgen [AMGN
Loading...
()
]
Gilead Sciences [GILD
Loading...
()
]
Amylin Pharmaceuticals [AMLN
Loading...
()
]
______________________________
Data is a real-time snapshot *Data is delayed at least 15 minutes